Discovery of abnormal GABA levels may lead to improvements in diagnosing, treating Alzheimer’s disease
June 18, 2014
A new drug target to fight Alzheimer’s disease has been discovered by a Penn State research team.
The discovery also has potential for development as a novel diagnostic tool for Alzheimer’s disease, which is the most common form of dementia and one for which no cure has yet been found.
A scientific paper describing the discovery was published in Nature Communications on June 13.
The… read more